RxDoctor Payments DataLook up a doctor →

Sanjay Dass, MD

Family Medicine · Little Rock, ARNPI 1265497242

Payments from drug & device makers

$13,819in general payments, 2019–2025

Across 497 payments — averaging $27.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • GSK$1K
  • Amgen$1K
  • Pfizer$896
  • Johnson & Johnson$727
  • plus $7K from 49 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)128$2,096
AstraZeneca35$1,282
GSK44$1,143
Amgen36$1,143
Pfizer46$896
Johnson & Johnson11$727
Lilly USA, LLC34$643
Vanda Pharmaceuticals Inc.13$573
Axsome Therapeutics, Inc.9$479
Novo Nordisk14$407
Otsuka America Pharmaceutical, Inc.4$326
Boehringer Ingelheim6$295
Abbott9$273
Teva Pharmaceuticals USA, Inc.8$265
Merck13$257
Idorsia Pharmaceuticals US Inc3$224
Sun Pharmaceutical Industries Inc.2$223
Eisai Inc.6$210
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$202
Paratek Pharmaceuticals, Inc.2$189
Ironshore Pharmaceuticals Inc.2$154
Supernus Pharmaceuticals, Inc.2$150
ARS Pharmaceuticals Operations, Inc.1$124
Boston Scientific3$114
Therapeuticsmd, Inc.1$114
Bayer2$103
Phathom Pharmaceuticals, Inc.1$102
Sumitomo Pharma America, Inc.1$97
Sanofi1$90
Jazz Pharmaceuticals Inc.1$86
Biohaven Pharmaceuticals, Inc.5$85
Galderma Laboratories, L.p.1$85
Dexcom, Inc.4$72
Astellas Pharma US Inc3$55
Exact Sciences3$45
Esperion Therapeutics, Inc.3$42
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$37
Amarin Pharma, Inc.2$34
Sanofi Pasteur Inc.2$34
Avanir Pharmaceuticals, Inc.2$32
Novartis2$31
Genentech USA, Inc.2$31
Lundbeck LLC2$31
Neuronetics, Inc.2$30
Takeda Pharmaceuticals U.S.A., Inc.1$24
Biogen1$22
Shield Therapeutics Inc1$20
Bioventus LLC1$19
Mylan Specialty L.p.1$17
Currax Pharmaceuticals LLC1$16
Mylan Pharmaceuticals Inc.1$16
Nevro Corp.1$15
Biohaven Pharmaceutical Holding Company Ltd.1$14
Shire North American Group Inc1$13
Upsher-smith Laboratories LLC1$13

How this compares

$13,819 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas →

Medicare billing

Part B allowed, 2024
$121,113
Medicare patients
350
Services billed
3,569

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Little Rock

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →